Recent studies have reported high expression of Gal-3 and Gal-9 in different tumors such as glioma [67,68], ovariancarcinoma [69], pancreatic ductal adenocarcinoma [70], chronic lymphocytic leukemia [71], and melanoma [23]. This evidence concerns the gene LGALS9 and pancreatic ductal adenocarcinoma.